Revenue | ₹322.86Cr |
Net Profits | ₹82.88Cr |
Net Profit Margins | 25.67% |
Suven Pharmaceuticals Ltd’s revenue jumped 37.88% since last year same period to ₹322.86Cr in the Q3 2024-2025. On a quarterly growth basis, Suven Pharmaceuticals Ltd has generated 18.77% jump in its revenue since last 3-months.
Suven Pharmaceuticals Ltd’s net profit jumped 77.28% since last year same period to ₹82.88Cr in the Q3 2024-2025. On a quarterly growth basis, Suven Pharmaceuticals Ltd has generated 0.81% jump in its net profits since last 3-months.
Suven Pharmaceuticals Ltd’s net profit margin jumped 28.58% since last year same period to 25.67% in the Q3 2024-2025. On a quarterly growth basis, Suven Pharmaceuticals Ltd has generated -15.12% fall in its net profit margins since last 3-months.
The revenue for Suven Pharmaceuticals Ltd in the Q3 results 2024 was ₹322.86Cr.
The net profit for Suven Pharmaceuticals Ltd in the Q3 results 2024 was ₹82.88Cr.
The net profit margin for Suven Pharmaceuticals Ltd in the Q3 results 2024 was 25.67%.
The revenue for Suven Pharmaceuticals Ltd in the Q3 results 2023 was ₹234.16Cr.
The net profit for Suven Pharmaceuticals Ltd in the Q3 results 2023 was ₹46.75Cr.
The net profit margin for Suven Pharmaceuticals Ltd in the Q3 results 2023 was 19.96%.